Coronary Heart Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients with identified myocardial infarction history, or coronary artery stenosis=50% on angioplasty or CTA examination, or keeping stable=1month after treatment of ACS(PCI or medicine intervention); (2) Aged between 18 and 75 years old; (3) Serum high-sensitivity C reactive protein level between 3 mg/L and 10 mg/L; (4) Patients providing written informed concents.
Exclusion criteria
Exclusion criteria: (1) Patients have a history of AMI, unstable angina, PCI or CABG within one month; (2) Combination with other heart desease or severe cardiopulmonary insufficiency; (3) Poor control of blood pressure (systolic pressure=160mmHg, or diastolic pressure =100mmHg); (4) Patients combined with acute cerebrovascular diseases; (5) Patients have a history of serious hepatic, renal, hematological,neurological,or severe psychiatric diseases; (6) Malignant arrhythmias (paroxysmal ventriculartachycardia) recurrent attacks; (7) women with pregnancy, planned pregnancy or lactating; (8) Subjects underwent surgical intervention on the skull or chest and abdomen within 4 weeks have a tendency to bleed; (9) Patients participated in other clinical trials within 1 month; (10) patients with allergy and are allergic to known components of the experimental.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cardiac death; Non fatal myocardial infarcion; coronary revascularization; | — |
Secondary
| Measure | Time frame |
|---|---|
| All cause of death;rehospitalization for ACS/heart failure/ malignant;Ischemic stroke;Other thrombotic complication; | — |
Countries
China
Contacts
Xiyuan Hospital, China Academy of Chinese Medical Sciences